Sheel Biotech signs MoU with ICAR-CISH for fruit innovation
Sheel Biotech Limited signed an MoU with ICAR-CISH on May 20, 2026, under the Fruit Horizon program to drive technology commercialization. The agreement aims to boost the company's strategic position in fruit innovation and support long-term growth.

*this image is generated using AI for illustrative purposes only.
Sheel Biotech Limited has formally executed a Memorandum of Understanding (MoU) with the Indian Council of Agricultural Research – Central Institute for Subtropical Horticulture (ICAR-CISH), Lucknow. The agreement falls under the “Fruit Horizon” program and was officially delivered on May 20, 2026, completing the procedural formalities that followed the initial signing on May 7, 2026.
The signing ceremony was attended by key dignitaries, including the Union Minister for Agriculture & Farmers’ Welfare and Rural Development, Shri Shivraj Singh Chouhan. State Ministers for agriculture and horticulture, along with senior officials from ICAR and the Director of CISH, Lucknow, were also present. Dr. Anju Bajpai, Principal Scientist & Head of the Division of Crop Improvement & Biotechnology, presented the MoU regarding technology commercialization.
Strategic Implications
This partnership is anticipated to enhance Sheel Biotech 's strategic positioning in the sector of fruit innovation. The collaboration focuses on technology commercialization, which is expected to contribute significantly to the company's long-term growth trajectory.
Key Details of the Agreement
| Aspect | Details |
|---|---|
| Partner | ICAR – Central Institute for Subtropical Horticulture (CISH), Lucknow |
| Program | Fruit Horizon |
| Initial Signing Date | May 7, 2026 |
| Formal Execution Date | May 20, 2026 |
| Focus Area | Technology Commercialization |
The company has submitted the necessary intimation to the National Stock Exchange of India Limited pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015.
Historical Stock Returns for Sheel Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.37% | -1.59% | -0.92% | -43.62% | -54.68% | -54.68% |
Which specific fruit crop technologies developed by ICAR-CISH is Sheel Biotech planning to commercialize first under the Fruit Horizon program?
How might this ICAR partnership influence Sheel Biotech's revenue projections and market share in India's horticulture biotechnology sector over the next 3-5 years?
Could this government-backed collaboration open doors for Sheel Biotech to secure additional public sector research partnerships or agricultural subsidies?

























